AstraZeneca (Japan) View Homepage


Ontology type: grid:Company  | foaf:Organization     


Organization Info

Publications in SciGraph latest 20 shown

  • 2019-03-26 A multicenter phase I study of inebilizumab, a humanized anti-CD19 monoclonal antibody, in Japanese patients with relapsed or refractory B-cell lymphoma and multiple myeloma in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2018-02 Rationale and Design for the J-DISCOVER Study: DISCOVERing the Treatment Reality of Type 2 Diabetes in a Real-World Setting in Japan—A Protocol in DIABETES THERAPY
  • 2017-08 Safety, tolerability and pharmacokinetics of the fibroblast growth factor receptor inhibitor AZD4547 in Japanese patients with advanced solid tumours: a Phase I study in INVESTIGATIONAL NEW DRUGS
  • 2016-04 Safety and tolerability of AZD5363 in Japanese patients with advanced solid tumors in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2015-09 A Phase I study of MEDI-575, a PDGFRα monoclonal antibody, in Japanese patients with advanced solid tumors in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2014-10 Inhibition of EGFR, HER2 and HER3 signaling with AZD8931 alone and in combination with paclitaxel: Phase I study in Japanese patients with advanced solid malignancies and advanced breast cancer in INVESTIGATIONAL NEW DRUGS
  • 2013-10 A Phase II study of polyclonal anti-TNF-α (AZD9773) in Japanese patients with severe sepsis and/or septic shock in JOURNAL OF INFECTION AND CHEMOTHERAPY
  • 2013-09 Industry and Regulatory Performance in 2012: A Year in Review in CLINICAL PHARMACOLOGY & THERAPEUTICS
  • 2013-06 Safety and tolerability of AZD8055 in Japanese patients with advanced solid tumors; a dose-finding phase I study in INVESTIGATIONAL NEW DRUGS
  • 2013-02 First report of the safety, tolerability, and pharmacokinetics of the Src kinase inhibitor saracatinib (AZD0530) in Japanese patients with advanced solid tumours in INVESTIGATIONAL NEW DRUGS
  • 2012-08 Phase I results from a two-part Phase I/II study of cediranib in combination with mFOLFOX6 in Japanese patients with metastatic colorectal cancer in INVESTIGATIONAL NEW DRUGS
  • 2009-11 Phase I, dose escalation and pharmacokinetic study of cediranib (RECENTIN™), a highly potent and selective VEGFR signaling inhibitor, in Japanese patients with advanced solid tumors in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2000-11 Clinical Dosage Determination of a New Aromatase Inhibitor, Anastrozole, in Postmenopausal Japanese Women with Advanced Breast Cancer in CLINICAL DRUG INVESTIGATION
  • JSON-LD is the canonical representation for SciGraph data.

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "foaf:homepage": [
          {
            "id": "https://www.astrazeneca.co.jp/"
          }
        ], 
        "grid:establishedYear": [
          {
            "@value": "1999-01-01", 
            "type": "http://www.w3.org/2001/XMLSchema#gYear"
          }
        ], 
        "grid:hasAddress": [
          {
            "id": "http://www.grid.ac/institutes/grid.476017.3/address-0"
          }
        ], 
        "grid:hasParent": [
          {
            "id": "http://www.grid.ac/institutes/grid.417815.e"
          }
        ], 
        "grid:id": [
          {
            "@value": "grid.476017.3"
          }
        ], 
        "grid:isni": [
          {
            "@value": "0000 0004 0376 5631"
          }
        ], 
        "grid:wikipediaPage": [
          {
            "id": "https://en.wikipedia.org/wiki/AstraZeneca"
          }
        ], 
        "id": "http://www.grid.ac/institutes/grid.476017.3", 
        "rdfs:label": "AstraZeneca (Japan)", 
        "sdDataset": "grid", 
        "skos:prefLabel": [
          {
            "@value": "AstraZeneca (Japan)"
          }
        ], 
        "type": [
          "http://xmlns.com/foaf/0.1/Organization", 
          "http://www.grid.ac/ontology/Company"
        ]
      }, 
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "foaf:homepage": [
          {
            "id": "http://www.astrazeneca.co.uk/home"
          }
        ], 
        "grid:crossrefFunderId": [
          {
            "@value": "501100004628"
          }, 
          {
            "@value": "100004325"
          }
        ], 
        "grid:establishedYear": [
          {
            "@value": "1999-01-01", 
            "type": "http://www.w3.org/2001/XMLSchema#gYear"
          }
        ], 
        "grid:hasAddress": [
          {
            "id": "http://www.grid.ac/institutes/grid.417815.e/address-0"
          }
        ], 
        "grid:hasChild": [
          {
            "id": "http://www.grid.ac/institutes/grid.487187.5"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.488280.e"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.467208.f"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.476017.3"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.476086.b"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.418152.b"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.476014.0"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.476010.4"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.487186.4"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.467202.5"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.487189.b"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.424144.3"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.459399.b"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.418151.8"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.476012.6"
          }
        ], 
        "grid:hasWikidataId": [
          {
            "id": "http://www.wikidata.org/entity/Q731938"
          }
        ], 
        "grid:id": [
          {
            "@value": "grid.417815.e"
          }
        ], 
        "grid:isni": [
          {
            "@value": "0000 0001 0433 5842"
          }
        ], 
        "grid:wikipediaPage": [
          {
            "id": "https://en.wikipedia.org/wiki/AstraZeneca"
          }
        ], 
        "id": "http://www.grid.ac/institutes/grid.417815.e", 
        "rdfs:label": "AstraZeneca (United Kingdom)", 
        "sdDataset": "grid", 
        "skos:prefLabel": [
          {
            "@value": "AstraZeneca (United Kingdom)"
          }
        ], 
        "type": [
          "http://www.grid.ac/ontology/Company", 
          "http://xmlns.com/foaf/0.1/Organization"
        ]
      }, 
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "geo-pos:lat": [
          {
            "@value": "34.704114", 
            "type": "http://www.w3.org/2001/XMLSchema#float"
          }
        ], 
        "geo-pos:long": [
          {
            "@value": "135.494839", 
            "type": "http://www.w3.org/2001/XMLSchema#float"
          }
        ], 
        "grid:cityName": [
          {
            "@value": "Osaka"
          }
        ], 
        "grid:countryCode": [
          {
            "@value": "JP"
          }
        ], 
        "grid:countryName": [
          {
            "@value": "Japan"
          }
        ], 
        "grid:hasGeonamesCity": [
          {
            "id": "http://sws.geonames.org/1853909/"
          }
        ], 
        "id": "http://www.grid.ac/institutes/grid.476017.3/address-0", 
        "sdDataset": "grid", 
        "type": [
          "http://www.grid.ac/ontology/Address"
        ]
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://www.grid.ac/institutes/grid.476017.3'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://www.grid.ac/institutes/grid.476017.3'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://www.grid.ac/institutes/grid.476017.3'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://www.grid.ac/institutes/grid.476017.3'


     

    This table displays all metadata directly associated to this object as RDF triples.

    49 TRIPLES      11 PREDICATES      12 URIs      5 LITERALS

    Subject Predicate Object
    1 grid-institutes:grid.476017.3 sgo:sdDataset grid
    2 grid:establishedYear 1999-01-01
    3 grid:hasAddress grid-institutes:grid.476017.3/address-0
    4 grid:hasParent grid-institutes:grid.417815.e
    5 grid:id grid.476017.3
    6 grid:isni 0000 0004 0376 5631
    7 grid:wikipediaPage https://en.wikipedia.org/wiki/AstraZeneca
    8 rdf:type grid:Company
    9 foaf:Organization
    10 rdfs:label AstraZeneca (Japan)
    11 skos:prefLabel AstraZeneca (Japan)
    12 foaf:homepage https://www.astrazeneca.co.jp/
    13 grid-institutes:grid.417815.e sgo:sdDataset grid
    14 grid:crossrefFunderId 100004325
    15 501100004628
    16 grid:establishedYear 1999-01-01
    17 grid:hasAddress grid-institutes:grid.417815.e/address-0
    18 grid:hasChild grid-institutes:grid.418151.8
    19 grid-institutes:grid.418152.b
    20 grid-institutes:grid.424144.3
    21 grid-institutes:grid.459399.b
    22 grid-institutes:grid.467202.5
    23 grid-institutes:grid.467208.f
    24 grid-institutes:grid.476010.4
    25 grid-institutes:grid.476012.6
    26 grid-institutes:grid.476014.0
    27 grid-institutes:grid.476017.3
    28 grid-institutes:grid.476086.b
    29 grid-institutes:grid.487186.4
    30 grid-institutes:grid.487187.5
    31 grid-institutes:grid.487189.b
    32 grid-institutes:grid.488280.e
    33 grid:hasWikidataId wd:Q731938
    34 grid:id grid.417815.e
    35 grid:isni 0000 0001 0433 5842
    36 grid:wikipediaPage https://en.wikipedia.org/wiki/AstraZeneca
    37 rdf:type grid:Company
    38 foaf:Organization
    39 rdfs:label AstraZeneca (United Kingdom)
    40 skos:prefLabel AstraZeneca (United Kingdom)
    41 foaf:homepage http://www.astrazeneca.co.uk/home
    42 grid-institutes:grid.476017.3/address-0 sgo:sdDataset grid
    43 grid:cityName Osaka
    44 grid:countryCode JP
    45 grid:countryName Japan
    46 grid:hasGeonamesCity http://sws.geonames.org/1853909/
    47 rdf:type grid:Address
    48 geo-pos:lat 34.704114
    49 geo-pos:long 135.494839
     




    Preview window. Press ESC to close (or click here)


    ...